COVID-19 Impact on Global Animal Blood Plasma and Derivatives, Market Insights and Forecast to 2026
Animal Blood Plasma and Derivatives market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Animal Blood Plasma and Derivatives market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Animal Blood Plasma and Derivatives market is segmented into
The Animal Blood Plasma and Derivatives market is analysed and market size information is provided by regions (countries).
The key regions covered in the Animal Blood Plasma and Derivatives market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Animal Blood Plasma and Derivatives Market Share Analysis
Animal Blood Plasma and Derivatives market competitive landscape provides details and data information by players.
The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Animal Blood Plasma and Derivatives business, the date to enter into the Animal Blood Plasma and Derivatives market, Animal Blood Plasma and Derivatives product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Animal Blood Plasma and Derivatives market is segmented into
- By Derivatives Type
- By Animal Type
- Food & Beverages
- Pharmaceuticals
- Cosmetics
- Feed
- Others
The Animal Blood Plasma and Derivatives market is analysed and market size information is provided by regions (countries).
The key regions covered in the Animal Blood Plasma and Derivatives market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Animal Blood Plasma and Derivatives Market Share Analysis
Animal Blood Plasma and Derivatives market competitive landscape provides details and data information by players.
The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Animal Blood Plasma and Derivatives business, the date to enter into the Animal Blood Plasma and Derivatives market, Animal Blood Plasma and Derivatives product introduction, recent developments, etc.
The major vendors covered:
- Proliant Inc.
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- Kraeber & Co GmbH
- LAMPIRE Biological Laboratories, Inc.
- Lake Immunogenics, Inc.
- Rocky Mountain Biologicals Inc.
- ANZCO Foods Ltd.
- Auckland BioSciences Ltd.
- Bovogen Biologicals Pty Ltd.
1 STUDY COVERAGE
1.1 Animal Blood Plasma and Derivatives Product Introduction
1.2 Market Segments
1.3 Key Animal Blood Plasma and Derivatives Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Animal Blood Plasma and Derivatives Market Size Growth Rate by Type
1.4.2 Type I
1.4.3 Type II
1.5 Market by Application
1.5.1 Global Animal Blood Plasma and Derivatives Market Size Growth Rate by Application
1.5.2 Food & Beverages
1.5.3 Pharmaceuticals
1.5.4 Cosmetics
1.5.5 Feed
1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19): Animal Blood Plasma and Derivatives Industry Impact
1.6.1 How the Covid-19 is Affecting the Animal Blood Plasma and Derivatives Industry
1.6.1.1 Animal Blood Plasma and Derivatives Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Animal Blood Plasma and Derivatives Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Animal Blood Plasma and Derivatives Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Animal Blood Plasma and Derivatives Market Size Estimates and Forecasts
2.1.1 Global Animal Blood Plasma and Derivatives Revenue 2015-2026
2.1.2 Global Animal Blood Plasma and Derivatives Sales 2015-2026
2.2 Animal Blood Plasma and Derivatives Market Size by Region: 2020 Versus 2026
2.2.1 Global Animal Blood Plasma and Derivatives Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Animal Blood Plasma and Derivatives Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL ANIMAL BLOOD PLASMA AND DERIVATIVES COMPETITOR LANDSCAPE BY PLAYERS
3.1 Animal Blood Plasma and Derivatives Sales by Manufacturers
3.1.1 Animal Blood Plasma and Derivatives Sales by Manufacturers (2015-2020)
3.1.2 Animal Blood Plasma and Derivatives Sales Market Share by Manufacturers (2015-2020)
3.2 Animal Blood Plasma and Derivatives Revenue by Manufacturers
3.2.1 Animal Blood Plasma and Derivatives Revenue by Manufacturers (2015-2020)
3.2.2 Animal Blood Plasma and Derivatives Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Animal Blood Plasma and Derivatives Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Animal Blood Plasma and Derivatives Revenue in 2019
3.2.5 Global Animal Blood Plasma and Derivatives Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Animal Blood Plasma and Derivatives Price by Manufacturers
3.4 Animal Blood Plasma and Derivatives Manufacturing Base Distribution, Product Types
3.4.1 Animal Blood Plasma and Derivatives Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Animal Blood Plasma and Derivatives Product Type
3.4.3 Date of International Manufacturers Enter into Animal Blood Plasma and Derivatives Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Animal Blood Plasma and Derivatives Market Size by Type (2015-2020)
4.1.1 Global Animal Blood Plasma and Derivatives Sales by Type (2015-2020)
4.1.2 Global Animal Blood Plasma and Derivatives Revenue by Type (2015-2020)
4.1.3 Animal Blood Plasma and Derivatives Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Animal Blood Plasma and Derivatives Market Size Forecast by Type (2021-2026)
4.2.1 Global Animal Blood Plasma and Derivatives Sales Forecast by Type (2021-2026)
4.2.2 Global Animal Blood Plasma and Derivatives Revenue Forecast by Type (2021-2026)
4.2.3 Animal Blood Plasma and Derivatives Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Animal Blood Plasma and Derivatives Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Animal Blood Plasma and Derivatives Market Size by Application (2015-2020)
5.1.1 Global Animal Blood Plasma and Derivatives Sales by Application (2015-2020)
5.1.2 Global Animal Blood Plasma and Derivatives Revenue by Application (2015-2020)
5.1.3 Animal Blood Plasma and Derivatives Price by Application (2015-2020)
5.2 Animal Blood Plasma and Derivatives Market Size Forecast by Application (2021-2026)
5.2.1 Global Animal Blood Plasma and Derivatives Sales Forecast by Application (2021-2026)
5.2.2 Global Animal Blood Plasma and Derivatives Revenue Forecast by Application (2021-2026)
5.2.3 Global Animal Blood Plasma and Derivatives Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Animal Blood Plasma and Derivatives by Country
6.1.1 North America Animal Blood Plasma and Derivatives Sales by Country
6.1.2 North America Animal Blood Plasma and Derivatives Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Animal Blood Plasma and Derivatives Market Facts & Figures by Type
6.3 North America Animal Blood Plasma and Derivatives Market Facts & Figures by Application
7 EUROPE
7.1 Europe Animal Blood Plasma and Derivatives by Country
7.1.1 Europe Animal Blood Plasma and Derivatives Sales by Country
7.1.2 Europe Animal Blood Plasma and Derivatives Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Animal Blood Plasma and Derivatives Market Facts & Figures by Type
7.3 Europe Animal Blood Plasma and Derivatives Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Animal Blood Plasma and Derivatives by Region
8.1.1 Asia Pacific Animal Blood Plasma and Derivatives Sales by Region
8.1.2 Asia Pacific Animal Blood Plasma and Derivatives Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Animal Blood Plasma and Derivatives Market Facts & Figures by Type
8.3 Asia Pacific Animal Blood Plasma and Derivatives Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Animal Blood Plasma and Derivatives by Country
9.1.1 Latin America Animal Blood Plasma and Derivatives Sales by Country
9.1.2 Latin America Animal Blood Plasma and Derivatives Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Animal Blood Plasma and Derivatives Market Facts & Figures by Type
9.3 Central & South America Animal Blood Plasma and Derivatives Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Animal Blood Plasma and Derivatives by Country
10.1.1 Middle East and Africa Animal Blood Plasma and Derivatives Sales by Country
10.1.2 Middle East and Africa Animal Blood Plasma and Derivatives Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Animal Blood Plasma and Derivatives Market Facts & Figures by Type
10.3 Middle East and Africa Animal Blood Plasma and Derivatives Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Proliant Inc.
11.1.1 Proliant Inc. Corporation Information
11.1.2 Proliant Inc. Description, Business Overview and Total Revenue
11.1.3 Proliant Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Proliant Inc. Animal Blood Plasma and Derivatives Products Offered
11.1.5 Proliant Inc. Recent Development
11.2 Thermo Fisher Scientific, Inc.
11.2.1 Thermo Fisher Scientific, Inc. Corporation Information
11.2.2 Thermo Fisher Scientific, Inc. Description, Business Overview and Total Revenue
11.2.3 Thermo Fisher Scientific, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Products Offered
11.2.5 Thermo Fisher Scientific, Inc. Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Corporation Information
11.3.2 Merck KGaA Description, Business Overview and Total Revenue
11.3.3 Merck KGaA Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merck KGaA Animal Blood Plasma and Derivatives Products Offered
11.3.5 Merck KGaA Recent Development
11.4 Kraeber & Co GmbH
11.4.1 Kraeber & Co GmbH Corporation Information
11.4.2 Kraeber & Co GmbH Description, Business Overview and Total Revenue
11.4.3 Kraeber & Co GmbH Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Kraeber & Co GmbH Animal Blood Plasma and Derivatives Products Offered
11.4.5 Kraeber & Co GmbH Recent Development
11.5 LAMPIRE Biological Laboratories, Inc.
11.5.1 LAMPIRE Biological Laboratories, Inc. Corporation Information
11.5.2 LAMPIRE Biological Laboratories, Inc. Description, Business Overview and Total Revenue
11.5.3 LAMPIRE Biological Laboratories, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Products Offered
11.5.5 LAMPIRE Biological Laboratories, Inc. Recent Development
11.6 Lake Immunogenics, Inc.
11.6.1 Lake Immunogenics, Inc. Corporation Information
11.6.2 Lake Immunogenics, Inc. Description, Business Overview and Total Revenue
11.6.3 Lake Immunogenics, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Products Offered
11.6.5 Lake Immunogenics, Inc. Recent Development
11.7 Rocky Mountain Biologicals Inc.
11.7.1 Rocky Mountain Biologicals Inc. Corporation Information
11.7.2 Rocky Mountain Biologicals Inc. Description, Business Overview and Total Revenue
11.7.3 Rocky Mountain Biologicals Inc. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Products Offered
11.7.5 Rocky Mountain Biologicals Inc. Recent Development
11.8 ANZCO Foods Ltd.
11.8.1 ANZCO Foods Ltd. Corporation Information
11.8.2 ANZCO Foods Ltd. Description, Business Overview and Total Revenue
11.8.3 ANZCO Foods Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.8.4 ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Products Offered
11.8.5 ANZCO Foods Ltd. Recent Development
11.9 Auckland BioSciences Ltd.
11.9.1 Auckland BioSciences Ltd. Corporation Information
11.9.2 Auckland BioSciences Ltd. Description, Business Overview and Total Revenue
11.9.3 Auckland BioSciences Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Products Offered
11.9.5 Auckland BioSciences Ltd. Recent Development
11.10 Bovogen Biologicals Pty Ltd.
11.10.1 Bovogen Biologicals Pty Ltd. Corporation Information
11.10.2 Bovogen Biologicals Pty Ltd. Description, Business Overview and Total Revenue
11.10.3 Bovogen Biologicals Pty Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Products Offered
11.10.5 Bovogen Biologicals Pty Ltd. Recent Development
11.1 Proliant Inc.
11.1.1 Proliant Inc. Corporation Information
11.1.2 Proliant Inc. Description, Business Overview and Total Revenue
11.1.3 Proliant Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Proliant Inc. Animal Blood Plasma and Derivatives Products Offered
11.1.5 Proliant Inc. Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Animal Blood Plasma and Derivatives Market Estimates and Projections by Region
12.1.1 Global Animal Blood Plasma and Derivatives Sales Forecast by Regions 2021-2026
12.1.2 Global Animal Blood Plasma and Derivatives Revenue Forecast by Regions 2021-2026
12.2 North America Animal Blood Plasma and Derivatives Market Size Forecast (2021-2026)
12.2.1 North America: Animal Blood Plasma and Derivatives Sales Forecast (2021-2026)
12.2.2 North America: Animal Blood Plasma and Derivatives Revenue Forecast (2021-2026)
12.2.3 North America: Animal Blood Plasma and Derivatives Market Size Forecast by Country (2021-2026)
12.3 Europe Animal Blood Plasma and Derivatives Market Size Forecast (2021-2026)
12.3.1 Europe: Animal Blood Plasma and Derivatives Sales Forecast (2021-2026)
12.3.2 Europe: Animal Blood Plasma and Derivatives Revenue Forecast (2021-2026)
12.3.3 Europe: Animal Blood Plasma and Derivatives Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Animal Blood Plasma and Derivatives Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Animal Blood Plasma and Derivatives Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Animal Blood Plasma and Derivatives Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Animal Blood Plasma and Derivatives Market Size Forecast by Region (2021-2026)
12.5 Latin America Animal Blood Plasma and Derivatives Market Size Forecast (2021-2026)
12.5.1 Latin America: Animal Blood Plasma and Derivatives Sales Forecast (2021-2026)
12.5.2 Latin America: Animal Blood Plasma and Derivatives Revenue Forecast (2021-2026)
12.5.3 Latin America: Animal Blood Plasma and Derivatives Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Animal Blood Plasma and Derivatives Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Animal Blood Plasma and Derivatives Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Animal Blood Plasma and Derivatives Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Animal Blood Plasma and Derivatives Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Animal Blood Plasma and Derivatives Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Animal Blood Plasma and Derivatives Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Animal Blood Plasma and Derivatives Product Introduction
1.2 Market Segments
1.3 Key Animal Blood Plasma and Derivatives Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Animal Blood Plasma and Derivatives Market Size Growth Rate by Type
1.4.2 Type I
1.4.3 Type II
1.5 Market by Application
1.5.1 Global Animal Blood Plasma and Derivatives Market Size Growth Rate by Application
1.5.2 Food & Beverages
1.5.3 Pharmaceuticals
1.5.4 Cosmetics
1.5.5 Feed
1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19): Animal Blood Plasma and Derivatives Industry Impact
1.6.1 How the Covid-19 is Affecting the Animal Blood Plasma and Derivatives Industry
1.6.1.1 Animal Blood Plasma and Derivatives Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Animal Blood Plasma and Derivatives Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Animal Blood Plasma and Derivatives Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Animal Blood Plasma and Derivatives Market Size Estimates and Forecasts
2.1.1 Global Animal Blood Plasma and Derivatives Revenue 2015-2026
2.1.2 Global Animal Blood Plasma and Derivatives Sales 2015-2026
2.2 Animal Blood Plasma and Derivatives Market Size by Region: 2020 Versus 2026
2.2.1 Global Animal Blood Plasma and Derivatives Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Animal Blood Plasma and Derivatives Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL ANIMAL BLOOD PLASMA AND DERIVATIVES COMPETITOR LANDSCAPE BY PLAYERS
3.1 Animal Blood Plasma and Derivatives Sales by Manufacturers
3.1.1 Animal Blood Plasma and Derivatives Sales by Manufacturers (2015-2020)
3.1.2 Animal Blood Plasma and Derivatives Sales Market Share by Manufacturers (2015-2020)
3.2 Animal Blood Plasma and Derivatives Revenue by Manufacturers
3.2.1 Animal Blood Plasma and Derivatives Revenue by Manufacturers (2015-2020)
3.2.2 Animal Blood Plasma and Derivatives Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Animal Blood Plasma and Derivatives Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Animal Blood Plasma and Derivatives Revenue in 2019
3.2.5 Global Animal Blood Plasma and Derivatives Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Animal Blood Plasma and Derivatives Price by Manufacturers
3.4 Animal Blood Plasma and Derivatives Manufacturing Base Distribution, Product Types
3.4.1 Animal Blood Plasma and Derivatives Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Animal Blood Plasma and Derivatives Product Type
3.4.3 Date of International Manufacturers Enter into Animal Blood Plasma and Derivatives Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Animal Blood Plasma and Derivatives Market Size by Type (2015-2020)
4.1.1 Global Animal Blood Plasma and Derivatives Sales by Type (2015-2020)
4.1.2 Global Animal Blood Plasma and Derivatives Revenue by Type (2015-2020)
4.1.3 Animal Blood Plasma and Derivatives Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Animal Blood Plasma and Derivatives Market Size Forecast by Type (2021-2026)
4.2.1 Global Animal Blood Plasma and Derivatives Sales Forecast by Type (2021-2026)
4.2.2 Global Animal Blood Plasma and Derivatives Revenue Forecast by Type (2021-2026)
4.2.3 Animal Blood Plasma and Derivatives Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Animal Blood Plasma and Derivatives Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Animal Blood Plasma and Derivatives Market Size by Application (2015-2020)
5.1.1 Global Animal Blood Plasma and Derivatives Sales by Application (2015-2020)
5.1.2 Global Animal Blood Plasma and Derivatives Revenue by Application (2015-2020)
5.1.3 Animal Blood Plasma and Derivatives Price by Application (2015-2020)
5.2 Animal Blood Plasma and Derivatives Market Size Forecast by Application (2021-2026)
5.2.1 Global Animal Blood Plasma and Derivatives Sales Forecast by Application (2021-2026)
5.2.2 Global Animal Blood Plasma and Derivatives Revenue Forecast by Application (2021-2026)
5.2.3 Global Animal Blood Plasma and Derivatives Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Animal Blood Plasma and Derivatives by Country
6.1.1 North America Animal Blood Plasma and Derivatives Sales by Country
6.1.2 North America Animal Blood Plasma and Derivatives Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Animal Blood Plasma and Derivatives Market Facts & Figures by Type
6.3 North America Animal Blood Plasma and Derivatives Market Facts & Figures by Application
7 EUROPE
7.1 Europe Animal Blood Plasma and Derivatives by Country
7.1.1 Europe Animal Blood Plasma and Derivatives Sales by Country
7.1.2 Europe Animal Blood Plasma and Derivatives Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Animal Blood Plasma and Derivatives Market Facts & Figures by Type
7.3 Europe Animal Blood Plasma and Derivatives Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Animal Blood Plasma and Derivatives by Region
8.1.1 Asia Pacific Animal Blood Plasma and Derivatives Sales by Region
8.1.2 Asia Pacific Animal Blood Plasma and Derivatives Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Animal Blood Plasma and Derivatives Market Facts & Figures by Type
8.3 Asia Pacific Animal Blood Plasma and Derivatives Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Animal Blood Plasma and Derivatives by Country
9.1.1 Latin America Animal Blood Plasma and Derivatives Sales by Country
9.1.2 Latin America Animal Blood Plasma and Derivatives Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Animal Blood Plasma and Derivatives Market Facts & Figures by Type
9.3 Central & South America Animal Blood Plasma and Derivatives Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Animal Blood Plasma and Derivatives by Country
10.1.1 Middle East and Africa Animal Blood Plasma and Derivatives Sales by Country
10.1.2 Middle East and Africa Animal Blood Plasma and Derivatives Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Animal Blood Plasma and Derivatives Market Facts & Figures by Type
10.3 Middle East and Africa Animal Blood Plasma and Derivatives Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Proliant Inc.
11.1.1 Proliant Inc. Corporation Information
11.1.2 Proliant Inc. Description, Business Overview and Total Revenue
11.1.3 Proliant Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Proliant Inc. Animal Blood Plasma and Derivatives Products Offered
11.1.5 Proliant Inc. Recent Development
11.2 Thermo Fisher Scientific, Inc.
11.2.1 Thermo Fisher Scientific, Inc. Corporation Information
11.2.2 Thermo Fisher Scientific, Inc. Description, Business Overview and Total Revenue
11.2.3 Thermo Fisher Scientific, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Products Offered
11.2.5 Thermo Fisher Scientific, Inc. Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Corporation Information
11.3.2 Merck KGaA Description, Business Overview and Total Revenue
11.3.3 Merck KGaA Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Merck KGaA Animal Blood Plasma and Derivatives Products Offered
11.3.5 Merck KGaA Recent Development
11.4 Kraeber & Co GmbH
11.4.1 Kraeber & Co GmbH Corporation Information
11.4.2 Kraeber & Co GmbH Description, Business Overview and Total Revenue
11.4.3 Kraeber & Co GmbH Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Kraeber & Co GmbH Animal Blood Plasma and Derivatives Products Offered
11.4.5 Kraeber & Co GmbH Recent Development
11.5 LAMPIRE Biological Laboratories, Inc.
11.5.1 LAMPIRE Biological Laboratories, Inc. Corporation Information
11.5.2 LAMPIRE Biological Laboratories, Inc. Description, Business Overview and Total Revenue
11.5.3 LAMPIRE Biological Laboratories, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Products Offered
11.5.5 LAMPIRE Biological Laboratories, Inc. Recent Development
11.6 Lake Immunogenics, Inc.
11.6.1 Lake Immunogenics, Inc. Corporation Information
11.6.2 Lake Immunogenics, Inc. Description, Business Overview and Total Revenue
11.6.3 Lake Immunogenics, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Products Offered
11.6.5 Lake Immunogenics, Inc. Recent Development
11.7 Rocky Mountain Biologicals Inc.
11.7.1 Rocky Mountain Biologicals Inc. Corporation Information
11.7.2 Rocky Mountain Biologicals Inc. Description, Business Overview and Total Revenue
11.7.3 Rocky Mountain Biologicals Inc. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Products Offered
11.7.5 Rocky Mountain Biologicals Inc. Recent Development
11.8 ANZCO Foods Ltd.
11.8.1 ANZCO Foods Ltd. Corporation Information
11.8.2 ANZCO Foods Ltd. Description, Business Overview and Total Revenue
11.8.3 ANZCO Foods Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.8.4 ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Products Offered
11.8.5 ANZCO Foods Ltd. Recent Development
11.9 Auckland BioSciences Ltd.
11.9.1 Auckland BioSciences Ltd. Corporation Information
11.9.2 Auckland BioSciences Ltd. Description, Business Overview and Total Revenue
11.9.3 Auckland BioSciences Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Products Offered
11.9.5 Auckland BioSciences Ltd. Recent Development
11.10 Bovogen Biologicals Pty Ltd.
11.10.1 Bovogen Biologicals Pty Ltd. Corporation Information
11.10.2 Bovogen Biologicals Pty Ltd. Description, Business Overview and Total Revenue
11.10.3 Bovogen Biologicals Pty Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Products Offered
11.10.5 Bovogen Biologicals Pty Ltd. Recent Development
11.1 Proliant Inc.
11.1.1 Proliant Inc. Corporation Information
11.1.2 Proliant Inc. Description, Business Overview and Total Revenue
11.1.3 Proliant Inc. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Proliant Inc. Animal Blood Plasma and Derivatives Products Offered
11.1.5 Proliant Inc. Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Animal Blood Plasma and Derivatives Market Estimates and Projections by Region
12.1.1 Global Animal Blood Plasma and Derivatives Sales Forecast by Regions 2021-2026
12.1.2 Global Animal Blood Plasma and Derivatives Revenue Forecast by Regions 2021-2026
12.2 North America Animal Blood Plasma and Derivatives Market Size Forecast (2021-2026)
12.2.1 North America: Animal Blood Plasma and Derivatives Sales Forecast (2021-2026)
12.2.2 North America: Animal Blood Plasma and Derivatives Revenue Forecast (2021-2026)
12.2.3 North America: Animal Blood Plasma and Derivatives Market Size Forecast by Country (2021-2026)
12.3 Europe Animal Blood Plasma and Derivatives Market Size Forecast (2021-2026)
12.3.1 Europe: Animal Blood Plasma and Derivatives Sales Forecast (2021-2026)
12.3.2 Europe: Animal Blood Plasma and Derivatives Revenue Forecast (2021-2026)
12.3.3 Europe: Animal Blood Plasma and Derivatives Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Animal Blood Plasma and Derivatives Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Animal Blood Plasma and Derivatives Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Animal Blood Plasma and Derivatives Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Animal Blood Plasma and Derivatives Market Size Forecast by Region (2021-2026)
12.5 Latin America Animal Blood Plasma and Derivatives Market Size Forecast (2021-2026)
12.5.1 Latin America: Animal Blood Plasma and Derivatives Sales Forecast (2021-2026)
12.5.2 Latin America: Animal Blood Plasma and Derivatives Revenue Forecast (2021-2026)
12.5.3 Latin America: Animal Blood Plasma and Derivatives Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Animal Blood Plasma and Derivatives Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Animal Blood Plasma and Derivatives Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Animal Blood Plasma and Derivatives Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Animal Blood Plasma and Derivatives Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Animal Blood Plasma and Derivatives Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Animal Blood Plasma and Derivatives Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Animal Blood Plasma and Derivatives Market Segments
Table 2. Ranking of Global Top Animal Blood Plasma and Derivatives Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Animal Blood Plasma and Derivatives Market Size Growth Rate by Type 2020-2026 (K L) & (US$ Million)
Table 4. Major Manufacturers of Type I
Table 5. Major Manufacturers of Type II
Table 6. COVID-19 Impact Global Market: (Four Animal Blood Plasma and Derivatives Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Animal Blood Plasma and Derivatives Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Animal Blood Plasma and Derivatives Players to Combat Covid-19 Impact
Table 11. Global Animal Blood Plasma and Derivatives Market Size Growth Rate by Application 2020-2026 (K L)
Table 12. Global Animal Blood Plasma and Derivatives Market Size by Region (K L) & (US$ Million): 2020 VS 2026
Table 13. Global Animal Blood Plasma and Derivatives Sales by Regions 2015-2020 (K L)
Table 14. Global Animal Blood Plasma and Derivatives Sales Market Share by Regions (2015-2020)
Table 15. Global Animal Blood Plasma and Derivatives Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Animal Blood Plasma and Derivatives Sales by Manufacturers (2015-2020) (K L)
Table 17. Global Animal Blood Plasma and Derivatives Sales Share by Manufacturers (2015-2020)
Table 18. Global Animal Blood Plasma and Derivatives Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Animal Blood Plasma and Derivatives by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Animal Blood Plasma and Derivatives as of 2019)
Table 20. Animal Blood Plasma and Derivatives Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Animal Blood Plasma and Derivatives Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Animal Blood Plasma and Derivatives Price (2015-2020) (USD/L)
Table 23. Animal Blood Plasma and Derivatives Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Animal Blood Plasma and Derivatives Product Type
Table 25. Date of International Manufacturers Enter into Animal Blood Plasma and Derivatives Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Animal Blood Plasma and Derivatives Sales by Type (2015-2020) (K L)
Table 28. Global Animal Blood Plasma and Derivatives Sales Share by Type (2015-2020)
Table 29. Global Animal Blood Plasma and Derivatives Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Animal Blood Plasma and Derivatives Revenue Share by Type (2015-2020)
Table 31. Animal Blood Plasma and Derivatives Average Selling Price (ASP) by Type 2015-2020 (USD/L)
Table 32. Global Animal Blood Plasma and Derivatives Sales by Application (2015-2020) (K L)
Table 33. Global Animal Blood Plasma and Derivatives Sales Share by Application (2015-2020)
Table 34. North America Animal Blood Plasma and Derivatives Sales by Country (2015-2020) (K L)
Table 35. North America Animal Blood Plasma and Derivatives Sales Market Share by Country (2015-2020)
Table 36. North America Animal Blood Plasma and Derivatives Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Animal Blood Plasma and Derivatives Revenue Market Share by Country (2015-2020)
Table 38. North America Animal Blood Plasma and Derivatives Sales by Type (2015-2020) (K L)
Table 39. North America Animal Blood Plasma and Derivatives Sales Market Share by Type (2015-2020)
Table 40. North America Animal Blood Plasma and Derivatives Sales by Application (2015-2020) (K L)
Table 41. North America Animal Blood Plasma and Derivatives Sales Market Share by Application (2015-2020)
Table 42. Europe Animal Blood Plasma and Derivatives Sales by Country (2015-2020) (K L)
Table 43. Europe Animal Blood Plasma and Derivatives Sales Market Share by Country (2015-2020)
Table 44. Europe Animal Blood Plasma and Derivatives Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Animal Blood Plasma and Derivatives Revenue Market Share by Country (2015-2020)
Table 46. Europe Animal Blood Plasma and Derivatives Sales by Type (2015-2020) (K L)
Table 47. Europe Animal Blood Plasma and Derivatives Sales Market Share by Type (2015-2020)
Table 48. Europe Animal Blood Plasma and Derivatives Sales by Application (2015-2020) (K L)
Table 49. Europe Animal Blood Plasma and Derivatives Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Animal Blood Plasma and Derivatives Sales by Region (2015-2020) (K L)
Table 51. Asia Pacific Animal Blood Plasma and Derivatives Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Animal Blood Plasma and Derivatives Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Animal Blood Plasma and Derivatives Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Animal Blood Plasma and Derivatives Sales by Type (2015-2020) (K L)
Table 55. Asia Pacific Animal Blood Plasma and Derivatives Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Animal Blood Plasma and Derivatives Sales by Application (2015-2020) (K L)
Table 57. Asia Pacific Animal Blood Plasma and Derivatives Sales Market Share by Application (2015-2020)
Table 58. Latin America Animal Blood Plasma and Derivatives Sales by Country (2015-2020) (K L)
Table 59. Latin America Animal Blood Plasma and Derivatives Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Animal Blood Plasma and Derivatives Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Animal Blood Plasma and Derivatives Revenue Market Share by Country (2015-2020)
Table 62. Latin America Animal Blood Plasma and Derivatives Sales by Type (2015-2020) (K L)
Table 63. Latin America Animal Blood Plasma and Derivatives Sales Market Share by Type (2015-2020)
Table 64. Latin America Animal Blood Plasma and Derivatives Sales by Application (2015-2020) (K L)
Table 65. Latin America Animal Blood Plasma and Derivatives Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Animal Blood Plasma and Derivatives Sales by Country (2015-2020) (K L)
Table 67. Middle East and Africa Animal Blood Plasma and Derivatives Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Animal Blood Plasma and Derivatives Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Animal Blood Plasma and Derivatives Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Animal Blood Plasma and Derivatives Sales by Type (2015-2020) (K L)
Table 71. Middle East and Africa Animal Blood Plasma and Derivatives Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Animal Blood Plasma and Derivatives Sales by Application (2015-2020) (K L)
Table 73. Middle East and Africa Animal Blood Plasma and Derivatives Sales Market Share by Application (2015-2020)
Table 74. Proliant Inc. Corporation Information
Table 75. Proliant Inc. Description and Major Businesses
Table 76. Proliant Inc. Animal Blood Plasma and Derivatives Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 77. Proliant Inc. Product
Table 78. Proliant Inc. Recent Development
Table 79. Thermo Fisher Scientific, Inc. Corporation Information
Table 80. Thermo Fisher Scientific, Inc. Description and Major Businesses
Table 81. Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 82. Thermo Fisher Scientific, Inc. Product
Table 83. Thermo Fisher Scientific, Inc. Recent Development
Table 84. Merck KGaA Corporation Information
Table 85. Merck KGaA Description and Major Businesses
Table 86. Merck KGaA Animal Blood Plasma and Derivatives Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 87. Merck KGaA Product
Table 88. Merck KGaA Recent Development
Table 89. Kraeber & Co GmbH Corporation Information
Table 90. Kraeber & Co GmbH Description and Major Businesses
Table 91. Kraeber & Co GmbH Animal Blood Plasma and Derivatives Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 92. Kraeber & Co GmbH Product
Table 93. Kraeber & Co GmbH Recent Development
Table 94. LAMPIRE Biological Laboratories, Inc. Corporation Information
Table 95. LAMPIRE Biological Laboratories, Inc. Description and Major Businesses
Table 96. LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 97. LAMPIRE Biological Laboratories, Inc. Product
Table 98. LAMPIRE Biological Laboratories, Inc. Recent Development
Table 99. Lake Immunogenics, Inc. Corporation Information
Table 100. Lake Immunogenics, Inc. Description and Major Businesses
Table 101. Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 102. Lake Immunogenics, Inc. Product
Table 103. Lake Immunogenics, Inc. Recent Development
Table 104. Rocky Mountain Biologicals Inc. Corporation Information
Table 105. Rocky Mountain Biologicals Inc. Description and Major Businesses
Table 106. Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 107. Rocky Mountain Biologicals Inc. Product
Table 108. Rocky Mountain Biologicals Inc. Recent Development
Table 109. ANZCO Foods Ltd. Corporation Information
Table 110. ANZCO Foods Ltd. Description and Major Businesses
Table 111. ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 112. ANZCO Foods Ltd. Product
Table 113. ANZCO Foods Ltd. Recent Development
Table 114. Auckland BioSciences Ltd. Corporation Information
Table 115. Auckland BioSciences Ltd. Description and Major Businesses
Table 116. Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 117. Auckland BioSciences Ltd. Product
Table 118. Auckland BioSciences Ltd. Recent Development
Table 119. Bovogen Biologicals Pty Ltd. Corporation Information
Table 120. Bovogen Biologicals Pty Ltd. Description and Major Businesses
Table 121. Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 122. Bovogen Biologicals Pty Ltd. Product
Table 123. Bovogen Biologicals Pty Ltd. Recent Development
Table 124. Global Animal Blood Plasma and Derivatives Sales Forecast by Regions (2021-2026) (K L)
Table 125. Global Animal Blood Plasma and Derivatives Sales Market Share Forecast by Regions (2021-2026)
Table 126. Global Animal Blood Plasma and Derivatives Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 127. Global Animal Blood Plasma and Derivatives Revenue Market Share Forecast by Regions (2021-2026)
Table 128. North America: Animal Blood Plasma and Derivatives Sales Forecast by Country (2021-2026) (K L)
Table 129. North America: Animal Blood Plasma and Derivatives Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Europe: Animal Blood Plasma and Derivatives Sales Forecast by Country (2021-2026) (K L)
Table 131. Europe: Animal Blood Plasma and Derivatives Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Asia Pacific: Animal Blood Plasma and Derivatives Sales Forecast by Region (2021-2026) (K L)
Table 133. Asia Pacific: Animal Blood Plasma and Derivatives Revenue Forecast by Region (2021-2026) (US$ Million)
Table 134. Latin America: Animal Blood Plasma and Derivatives Sales Forecast by Country (2021-2026) (K L)
Table 135. Latin America: Animal Blood Plasma and Derivatives Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Middle East and Africa: Animal Blood Plasma and Derivatives Sales Forecast by Country (2021-2026) (K L)
Table 137. Middle East and Africa: Animal Blood Plasma and Derivatives Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 139. Key Challenges
Table 140. Market Risks
Table 141. Main Points Interviewed from Key Animal Blood Plasma and Derivatives Players
Table 142. Animal Blood Plasma and Derivatives Customers List
Table 143. Animal Blood Plasma and Derivatives Distributors List
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
Table 1. Animal Blood Plasma and Derivatives Market Segments
Table 2. Ranking of Global Top Animal Blood Plasma and Derivatives Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Animal Blood Plasma and Derivatives Market Size Growth Rate by Type 2020-2026 (K L) & (US$ Million)
Table 4. Major Manufacturers of Type I
Table 5. Major Manufacturers of Type II
Table 6. COVID-19 Impact Global Market: (Four Animal Blood Plasma and Derivatives Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Animal Blood Plasma and Derivatives Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Animal Blood Plasma and Derivatives Players to Combat Covid-19 Impact
Table 11. Global Animal Blood Plasma and Derivatives Market Size Growth Rate by Application 2020-2026 (K L)
Table 12. Global Animal Blood Plasma and Derivatives Market Size by Region (K L) & (US$ Million): 2020 VS 2026
Table 13. Global Animal Blood Plasma and Derivatives Sales by Regions 2015-2020 (K L)
Table 14. Global Animal Blood Plasma and Derivatives Sales Market Share by Regions (2015-2020)
Table 15. Global Animal Blood Plasma and Derivatives Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Animal Blood Plasma and Derivatives Sales by Manufacturers (2015-2020) (K L)
Table 17. Global Animal Blood Plasma and Derivatives Sales Share by Manufacturers (2015-2020)
Table 18. Global Animal Blood Plasma and Derivatives Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Animal Blood Plasma and Derivatives by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Animal Blood Plasma and Derivatives as of 2019)
Table 20. Animal Blood Plasma and Derivatives Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Animal Blood Plasma and Derivatives Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Animal Blood Plasma and Derivatives Price (2015-2020) (USD/L)
Table 23. Animal Blood Plasma and Derivatives Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Animal Blood Plasma and Derivatives Product Type
Table 25. Date of International Manufacturers Enter into Animal Blood Plasma and Derivatives Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Animal Blood Plasma and Derivatives Sales by Type (2015-2020) (K L)
Table 28. Global Animal Blood Plasma and Derivatives Sales Share by Type (2015-2020)
Table 29. Global Animal Blood Plasma and Derivatives Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Animal Blood Plasma and Derivatives Revenue Share by Type (2015-2020)
Table 31. Animal Blood Plasma and Derivatives Average Selling Price (ASP) by Type 2015-2020 (USD/L)
Table 32. Global Animal Blood Plasma and Derivatives Sales by Application (2015-2020) (K L)
Table 33. Global Animal Blood Plasma and Derivatives Sales Share by Application (2015-2020)
Table 34. North America Animal Blood Plasma and Derivatives Sales by Country (2015-2020) (K L)
Table 35. North America Animal Blood Plasma and Derivatives Sales Market Share by Country (2015-2020)
Table 36. North America Animal Blood Plasma and Derivatives Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Animal Blood Plasma and Derivatives Revenue Market Share by Country (2015-2020)
Table 38. North America Animal Blood Plasma and Derivatives Sales by Type (2015-2020) (K L)
Table 39. North America Animal Blood Plasma and Derivatives Sales Market Share by Type (2015-2020)
Table 40. North America Animal Blood Plasma and Derivatives Sales by Application (2015-2020) (K L)
Table 41. North America Animal Blood Plasma and Derivatives Sales Market Share by Application (2015-2020)
Table 42. Europe Animal Blood Plasma and Derivatives Sales by Country (2015-2020) (K L)
Table 43. Europe Animal Blood Plasma and Derivatives Sales Market Share by Country (2015-2020)
Table 44. Europe Animal Blood Plasma and Derivatives Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Animal Blood Plasma and Derivatives Revenue Market Share by Country (2015-2020)
Table 46. Europe Animal Blood Plasma and Derivatives Sales by Type (2015-2020) (K L)
Table 47. Europe Animal Blood Plasma and Derivatives Sales Market Share by Type (2015-2020)
Table 48. Europe Animal Blood Plasma and Derivatives Sales by Application (2015-2020) (K L)
Table 49. Europe Animal Blood Plasma and Derivatives Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Animal Blood Plasma and Derivatives Sales by Region (2015-2020) (K L)
Table 51. Asia Pacific Animal Blood Plasma and Derivatives Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Animal Blood Plasma and Derivatives Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Animal Blood Plasma and Derivatives Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Animal Blood Plasma and Derivatives Sales by Type (2015-2020) (K L)
Table 55. Asia Pacific Animal Blood Plasma and Derivatives Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Animal Blood Plasma and Derivatives Sales by Application (2015-2020) (K L)
Table 57. Asia Pacific Animal Blood Plasma and Derivatives Sales Market Share by Application (2015-2020)
Table 58. Latin America Animal Blood Plasma and Derivatives Sales by Country (2015-2020) (K L)
Table 59. Latin America Animal Blood Plasma and Derivatives Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Animal Blood Plasma and Derivatives Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Animal Blood Plasma and Derivatives Revenue Market Share by Country (2015-2020)
Table 62. Latin America Animal Blood Plasma and Derivatives Sales by Type (2015-2020) (K L)
Table 63. Latin America Animal Blood Plasma and Derivatives Sales Market Share by Type (2015-2020)
Table 64. Latin America Animal Blood Plasma and Derivatives Sales by Application (2015-2020) (K L)
Table 65. Latin America Animal Blood Plasma and Derivatives Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Animal Blood Plasma and Derivatives Sales by Country (2015-2020) (K L)
Table 67. Middle East and Africa Animal Blood Plasma and Derivatives Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Animal Blood Plasma and Derivatives Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Animal Blood Plasma and Derivatives Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Animal Blood Plasma and Derivatives Sales by Type (2015-2020) (K L)
Table 71. Middle East and Africa Animal Blood Plasma and Derivatives Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Animal Blood Plasma and Derivatives Sales by Application (2015-2020) (K L)
Table 73. Middle East and Africa Animal Blood Plasma and Derivatives Sales Market Share by Application (2015-2020)
Table 74. Proliant Inc. Corporation Information
Table 75. Proliant Inc. Description and Major Businesses
Table 76. Proliant Inc. Animal Blood Plasma and Derivatives Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 77. Proliant Inc. Product
Table 78. Proliant Inc. Recent Development
Table 79. Thermo Fisher Scientific, Inc. Corporation Information
Table 80. Thermo Fisher Scientific, Inc. Description and Major Businesses
Table 81. Thermo Fisher Scientific, Inc. Animal Blood Plasma and Derivatives Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 82. Thermo Fisher Scientific, Inc. Product
Table 83. Thermo Fisher Scientific, Inc. Recent Development
Table 84. Merck KGaA Corporation Information
Table 85. Merck KGaA Description and Major Businesses
Table 86. Merck KGaA Animal Blood Plasma and Derivatives Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 87. Merck KGaA Product
Table 88. Merck KGaA Recent Development
Table 89. Kraeber & Co GmbH Corporation Information
Table 90. Kraeber & Co GmbH Description and Major Businesses
Table 91. Kraeber & Co GmbH Animal Blood Plasma and Derivatives Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 92. Kraeber & Co GmbH Product
Table 93. Kraeber & Co GmbH Recent Development
Table 94. LAMPIRE Biological Laboratories, Inc. Corporation Information
Table 95. LAMPIRE Biological Laboratories, Inc. Description and Major Businesses
Table 96. LAMPIRE Biological Laboratories, Inc. Animal Blood Plasma and Derivatives Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 97. LAMPIRE Biological Laboratories, Inc. Product
Table 98. LAMPIRE Biological Laboratories, Inc. Recent Development
Table 99. Lake Immunogenics, Inc. Corporation Information
Table 100. Lake Immunogenics, Inc. Description and Major Businesses
Table 101. Lake Immunogenics, Inc. Animal Blood Plasma and Derivatives Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 102. Lake Immunogenics, Inc. Product
Table 103. Lake Immunogenics, Inc. Recent Development
Table 104. Rocky Mountain Biologicals Inc. Corporation Information
Table 105. Rocky Mountain Biologicals Inc. Description and Major Businesses
Table 106. Rocky Mountain Biologicals Inc. Animal Blood Plasma and Derivatives Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 107. Rocky Mountain Biologicals Inc. Product
Table 108. Rocky Mountain Biologicals Inc. Recent Development
Table 109. ANZCO Foods Ltd. Corporation Information
Table 110. ANZCO Foods Ltd. Description and Major Businesses
Table 111. ANZCO Foods Ltd. Animal Blood Plasma and Derivatives Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 112. ANZCO Foods Ltd. Product
Table 113. ANZCO Foods Ltd. Recent Development
Table 114. Auckland BioSciences Ltd. Corporation Information
Table 115. Auckland BioSciences Ltd. Description and Major Businesses
Table 116. Auckland BioSciences Ltd. Animal Blood Plasma and Derivatives Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 117. Auckland BioSciences Ltd. Product
Table 118. Auckland BioSciences Ltd. Recent Development
Table 119. Bovogen Biologicals Pty Ltd. Corporation Information
Table 120. Bovogen Biologicals Pty Ltd. Description and Major Businesses
Table 121. Bovogen Biologicals Pty Ltd. Animal Blood Plasma and Derivatives Production (K L), Revenue (US$ Million), Price (USD/L) and Gross Margin (2015-2020)
Table 122. Bovogen Biologicals Pty Ltd. Product
Table 123. Bovogen Biologicals Pty Ltd. Recent Development
Table 124. Global Animal Blood Plasma and Derivatives Sales Forecast by Regions (2021-2026) (K L)
Table 125. Global Animal Blood Plasma and Derivatives Sales Market Share Forecast by Regions (2021-2026)
Table 126. Global Animal Blood Plasma and Derivatives Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 127. Global Animal Blood Plasma and Derivatives Revenue Market Share Forecast by Regions (2021-2026)
Table 128. North America: Animal Blood Plasma and Derivatives Sales Forecast by Country (2021-2026) (K L)
Table 129. North America: Animal Blood Plasma and Derivatives Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Europe: Animal Blood Plasma and Derivatives Sales Forecast by Country (2021-2026) (K L)
Table 131. Europe: Animal Blood Plasma and Derivatives Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Asia Pacific: Animal Blood Plasma and Derivatives Sales Forecast by Region (2021-2026) (K L)
Table 133. Asia Pacific: Animal Blood Plasma and Derivatives Revenue Forecast by Region (2021-2026) (US$ Million)
Table 134. Latin America: Animal Blood Plasma and Derivatives Sales Forecast by Country (2021-2026) (K L)
Table 135. Latin America: Animal Blood Plasma and Derivatives Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Middle East and Africa: Animal Blood Plasma and Derivatives Sales Forecast by Country (2021-2026) (K L)
Table 137. Middle East and Africa: Animal Blood Plasma and Derivatives Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 139. Key Challenges
Table 140. Market Risks
Table 141. Main Points Interviewed from Key Animal Blood Plasma and Derivatives Players
Table 142. Animal Blood Plasma and Derivatives Customers List
Table 143. Animal Blood Plasma and Derivatives Distributors List
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Animal Blood Plasma and Derivatives Product Picture
Figure 2. Global Animal Blood Plasma and Derivatives Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Animal Blood Plasma and Derivatives Sales Market Share by Application in 2020 & 2026
Figure 6. Food & Beverages
Figure 7. Pharmaceuticals
Figure 8. Cosmetics
Figure 9. Feed
Figure 10. Others
Figure 11. Animal Blood Plasma and Derivatives Report Years Considered
Figure 12. Global Animal Blood Plasma and Derivatives Market Size 2015-2026 (US$ Million)
Figure 13. Global Animal Blood Plasma and Derivatives Sales 2015-2026 (K L)
Figure 14. Global Animal Blood Plasma and Derivatives Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Animal Blood Plasma and Derivatives Sales Market Share by Region (2015-2020)
Figure 16. Global Animal Blood Plasma and Derivatives Sales Market Share by Region in 2019
Figure 17. Global Animal Blood Plasma and Derivatives Revenue Market Share by Region (2015-2020)
Figure 18. Global Animal Blood Plasma and Derivatives Revenue Market Share by Region in 2019
Figure 19. Global Animal Blood Plasma and Derivatives Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Animal Blood Plasma and Derivatives Revenue in 2019
Figure 21. Animal Blood Plasma and Derivatives Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Animal Blood Plasma and Derivatives Sales Market Share by Type (2015-2020)
Figure 23. Global Animal Blood Plasma and Derivatives Sales Market Share by Type in 2019
Figure 24. Global Animal Blood Plasma and Derivatives Revenue Market Share by Type (2015-2020)
Figure 25. Global Animal Blood Plasma and Derivatives Revenue Market Share by Type in 2019
Figure 26. Global Animal Blood Plasma and Derivatives Market Share by Price Range (2015-2020)
Figure 27. Global Animal Blood Plasma and Derivatives Sales Market Share by Application (2015-2020)
Figure 28. Global Animal Blood Plasma and Derivatives Sales Market Share by Application in 2019
Figure 29. Global Animal Blood Plasma and Derivatives Revenue Market Share by Application (2015-2020)
Figure 30. Global Animal Blood Plasma and Derivatives Revenue Market Share by Application in 2019
Figure 31. North America Animal Blood Plasma and Derivatives Sales Growth Rate 2015-2020 (K L)
Figure 32. North America Animal Blood Plasma and Derivatives Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Animal Blood Plasma and Derivatives Sales Market Share by Country in 2019
Figure 34. North America Animal Blood Plasma and Derivatives Revenue Market Share by Country in 2019
Figure 35. U.S. Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 36. U.S. Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 38. Canada Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Animal Blood Plasma and Derivatives Market Share by Type in 2019
Figure 40. North America Animal Blood Plasma and Derivatives Market Share by Application in 2019
Figure 41. Europe Animal Blood Plasma and Derivatives Sales Growth Rate 2015-2020 (K L)
Figure 42. Europe Animal Blood Plasma and Derivatives Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Animal Blood Plasma and Derivatives Sales Market Share by Country in 2019
Figure 44. Europe Animal Blood Plasma and Derivatives Revenue Market Share by Country in 2019
Figure 45. Germany Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 46. Germany Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 48. France Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 50. U.K. Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 52. Italy Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 54. Russia Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Animal Blood Plasma and Derivatives Market Share by Type in 2019
Figure 56. Europe Animal Blood Plasma and Derivatives Market Share by Application in 2019
Figure 57. Asia Pacific Animal Blood Plasma and Derivatives Sales Growth Rate 2015-2020 (K L)
Figure 58. Asia Pacific Animal Blood Plasma and Derivatives Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Animal Blood Plasma and Derivatives Sales Market Share by Region in 2019
Figure 60. Asia Pacific Animal Blood Plasma and Derivatives Revenue Market Share by Region in 2019
Figure 61. China Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 62. China Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 64. Japan Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 66. South Korea Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 68. India Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 70. Australia Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 72. Taiwan Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 74. Indonesia Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 76. Thailand Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 78. Malaysia Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 80. Philippines Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 82. Vietnam Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Animal Blood Plasma and Derivatives Market Share by Type in 2019
Figure 84. Asia Pacific Animal Blood Plasma and Derivatives Market Share by Application in 2019
Figure 85. Latin America Animal Blood Plasma and Derivatives Sales Growth Rate 2015-2020 (K L)
Figure 86. Latin America Animal Blood Plasma and Derivatives Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Animal Blood Plasma and Derivatives Sales Market Share by Country in 2019
Figure 88. Latin America Animal Blood Plasma and Derivatives Revenue Market Share by Country in 2019
Figure 89. Mexico Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 90. Mexico Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 92. Brazil Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 94. Argentina Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Animal Blood Plasma and Derivatives Market Share by Type in 2019
Figure 96. Latin America Animal Blood Plasma and Derivatives Market Share by Application in 2019
Figure 97. Middle East and Africa Animal Blood Plasma and Derivatives Sales Growth Rate 2015-2020 (K L)
Figure 98. Middle East and Africa Animal Blood Plasma and Derivatives Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Animal Blood Plasma and Derivatives Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Animal Blood Plasma and Derivatives Revenue Market Share by Country in 2019
Figure 101. Turkey Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 102. Turkey Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 104. Saudi Arabia Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 106. U.A.E Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Animal Blood Plasma and Derivatives Market Share by Type in 2019
Figure 108. Middle East and Africa Animal Blood Plasma and Derivatives Market Share by Application in 2019
Figure 109. Proliant Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Thermo Fisher Scientific, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Merck KGaA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Kraeber & Co GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. LAMPIRE Biological Laboratories, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Lake Immunogenics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Rocky Mountain Biologicals Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. ANZCO Foods Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Auckland BioSciences Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Bovogen Biologicals Pty Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. North America Animal Blood Plasma and Derivatives Sales Growth Rate Forecast (2021-2026) (K L)
Figure 120. North America Animal Blood Plasma and Derivatives Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Europe Animal Blood Plasma and Derivatives Sales Growth Rate Forecast (2021-2026) (K L)
Figure 122. Europe Animal Blood Plasma and Derivatives Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Asia Pacific Animal Blood Plasma and Derivatives Sales Growth Rate Forecast (2021-2026) (K L)
Figure 124. Asia Pacific Animal Blood Plasma and Derivatives Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Latin America Animal Blood Plasma and Derivatives Sales Growth Rate Forecast (2021-2026) (K L)
Figure 126. Latin America Animal Blood Plasma and Derivatives Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Middle East and Africa Animal Blood Plasma and Derivatives Sales Growth Rate Forecast (2021-2026) (K L)
Figure 128. Middle East and Africa Animal Blood Plasma and Derivatives Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Porter's Five Forces Analysis
Figure 130. Channels of Distribution
Figure 131. Distributors Profiles
Figure 132. Bottom-up and Top-down Approaches for This Report
Figure 133. Data Triangulation
Figure 134. Key Executives Interviewed
Figure 1. Animal Blood Plasma and Derivatives Product Picture
Figure 2. Global Animal Blood Plasma and Derivatives Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Animal Blood Plasma and Derivatives Sales Market Share by Application in 2020 & 2026
Figure 6. Food & Beverages
Figure 7. Pharmaceuticals
Figure 8. Cosmetics
Figure 9. Feed
Figure 10. Others
Figure 11. Animal Blood Plasma and Derivatives Report Years Considered
Figure 12. Global Animal Blood Plasma and Derivatives Market Size 2015-2026 (US$ Million)
Figure 13. Global Animal Blood Plasma and Derivatives Sales 2015-2026 (K L)
Figure 14. Global Animal Blood Plasma and Derivatives Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Animal Blood Plasma and Derivatives Sales Market Share by Region (2015-2020)
Figure 16. Global Animal Blood Plasma and Derivatives Sales Market Share by Region in 2019
Figure 17. Global Animal Blood Plasma and Derivatives Revenue Market Share by Region (2015-2020)
Figure 18. Global Animal Blood Plasma and Derivatives Revenue Market Share by Region in 2019
Figure 19. Global Animal Blood Plasma and Derivatives Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Animal Blood Plasma and Derivatives Revenue in 2019
Figure 21. Animal Blood Plasma and Derivatives Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Animal Blood Plasma and Derivatives Sales Market Share by Type (2015-2020)
Figure 23. Global Animal Blood Plasma and Derivatives Sales Market Share by Type in 2019
Figure 24. Global Animal Blood Plasma and Derivatives Revenue Market Share by Type (2015-2020)
Figure 25. Global Animal Blood Plasma and Derivatives Revenue Market Share by Type in 2019
Figure 26. Global Animal Blood Plasma and Derivatives Market Share by Price Range (2015-2020)
Figure 27. Global Animal Blood Plasma and Derivatives Sales Market Share by Application (2015-2020)
Figure 28. Global Animal Blood Plasma and Derivatives Sales Market Share by Application in 2019
Figure 29. Global Animal Blood Plasma and Derivatives Revenue Market Share by Application (2015-2020)
Figure 30. Global Animal Blood Plasma and Derivatives Revenue Market Share by Application in 2019
Figure 31. North America Animal Blood Plasma and Derivatives Sales Growth Rate 2015-2020 (K L)
Figure 32. North America Animal Blood Plasma and Derivatives Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Animal Blood Plasma and Derivatives Sales Market Share by Country in 2019
Figure 34. North America Animal Blood Plasma and Derivatives Revenue Market Share by Country in 2019
Figure 35. U.S. Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 36. U.S. Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 38. Canada Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Animal Blood Plasma and Derivatives Market Share by Type in 2019
Figure 40. North America Animal Blood Plasma and Derivatives Market Share by Application in 2019
Figure 41. Europe Animal Blood Plasma and Derivatives Sales Growth Rate 2015-2020 (K L)
Figure 42. Europe Animal Blood Plasma and Derivatives Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Animal Blood Plasma and Derivatives Sales Market Share by Country in 2019
Figure 44. Europe Animal Blood Plasma and Derivatives Revenue Market Share by Country in 2019
Figure 45. Germany Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 46. Germany Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 48. France Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 50. U.K. Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 52. Italy Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 54. Russia Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Animal Blood Plasma and Derivatives Market Share by Type in 2019
Figure 56. Europe Animal Blood Plasma and Derivatives Market Share by Application in 2019
Figure 57. Asia Pacific Animal Blood Plasma and Derivatives Sales Growth Rate 2015-2020 (K L)
Figure 58. Asia Pacific Animal Blood Plasma and Derivatives Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Animal Blood Plasma and Derivatives Sales Market Share by Region in 2019
Figure 60. Asia Pacific Animal Blood Plasma and Derivatives Revenue Market Share by Region in 2019
Figure 61. China Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 62. China Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 64. Japan Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 66. South Korea Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 68. India Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 70. Australia Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 72. Taiwan Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 74. Indonesia Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 76. Thailand Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 78. Malaysia Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 80. Philippines Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 82. Vietnam Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Animal Blood Plasma and Derivatives Market Share by Type in 2019
Figure 84. Asia Pacific Animal Blood Plasma and Derivatives Market Share by Application in 2019
Figure 85. Latin America Animal Blood Plasma and Derivatives Sales Growth Rate 2015-2020 (K L)
Figure 86. Latin America Animal Blood Plasma and Derivatives Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Animal Blood Plasma and Derivatives Sales Market Share by Country in 2019
Figure 88. Latin America Animal Blood Plasma and Derivatives Revenue Market Share by Country in 2019
Figure 89. Mexico Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 90. Mexico Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 92. Brazil Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 94. Argentina Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Animal Blood Plasma and Derivatives Market Share by Type in 2019
Figure 96. Latin America Animal Blood Plasma and Derivatives Market Share by Application in 2019
Figure 97. Middle East and Africa Animal Blood Plasma and Derivatives Sales Growth Rate 2015-2020 (K L)
Figure 98. Middle East and Africa Animal Blood Plasma and Derivatives Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Animal Blood Plasma and Derivatives Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Animal Blood Plasma and Derivatives Revenue Market Share by Country in 2019
Figure 101. Turkey Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 102. Turkey Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 104. Saudi Arabia Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Animal Blood Plasma and Derivatives Sales Growth Rate (2015-2020) (K L)
Figure 106. U.A.E Animal Blood Plasma and Derivatives Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Animal Blood Plasma and Derivatives Market Share by Type in 2019
Figure 108. Middle East and Africa Animal Blood Plasma and Derivatives Market Share by Application in 2019
Figure 109. Proliant Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Thermo Fisher Scientific, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Merck KGaA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Kraeber & Co GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. LAMPIRE Biological Laboratories, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Lake Immunogenics, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Rocky Mountain Biologicals Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. ANZCO Foods Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Auckland BioSciences Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Bovogen Biologicals Pty Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. North America Animal Blood Plasma and Derivatives Sales Growth Rate Forecast (2021-2026) (K L)
Figure 120. North America Animal Blood Plasma and Derivatives Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Europe Animal Blood Plasma and Derivatives Sales Growth Rate Forecast (2021-2026) (K L)
Figure 122. Europe Animal Blood Plasma and Derivatives Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Asia Pacific Animal Blood Plasma and Derivatives Sales Growth Rate Forecast (2021-2026) (K L)
Figure 124. Asia Pacific Animal Blood Plasma and Derivatives Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Latin America Animal Blood Plasma and Derivatives Sales Growth Rate Forecast (2021-2026) (K L)
Figure 126. Latin America Animal Blood Plasma and Derivatives Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Middle East and Africa Animal Blood Plasma and Derivatives Sales Growth Rate Forecast (2021-2026) (K L)
Figure 128. Middle East and Africa Animal Blood Plasma and Derivatives Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Porter's Five Forces Analysis
Figure 130. Channels of Distribution
Figure 131. Distributors Profiles
Figure 132. Bottom-up and Top-down Approaches for This Report
Figure 133. Data Triangulation
Figure 134. Key Executives Interviewed
